Seroatlas · Human Serome Atlas

GPD1L

Glycerol-3-phosphate dehydrogenase 1-like protein

Also known as: GPD1L_HUMAN, KIAA0089

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8N335
Gene
GPD1L
Ensembl
ENSG00000152642
Chromosome
3
Canonical length
351 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins

OverviewNCBI Gene

The protein encoded by this gene catalyzes the conversion of sn-glycerol 3-phosphate to glycerone phosphate. The encoded protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). Defects in this gene are a cause of Brugada syndrome type 2 (BRS2) as well as sudden infant death syndrome (SIDS). [provided by RefSeq, Jul 2010]

Canonical amino-acid sequenceUniProt

351 residues, UniProt reviewed canonical sequence.

>Q8N335|GPD1L
     1  MAAAPLKVCI VGSGNWGSAV AKIIGNNVKK LQKFASTVKM WVFEETVNGR KLTDIINNDH
    61  ENVKYLPGHK LPENVVAMSN LSEAVQDADL LVFVIPHQFI HRICDEITGR VPKKALGITL
   121  IKGIDEGPEG LKLISDIIRE KMGIDISVLM GANIANEVAA EKFCETTIGS KVMENGLLFK
   181  ELLQTPNFRI TVVDDADTVE LCGALKNIVA VGAGFCDGLR CGDNTKAAVI RLGLMEMIAF
   241  ARIFCKGQVS TATFLESCGV ADLITTCYGG RNRRVAEAFA RTGKTIEELE KEMLNGQKLQ
   301  GPQTSAEVYR ILKQKGLLDK FPLFTAVYQI CYESRPVQEM LSCLQSHPEH T

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GPD1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.22
Highest tissue expression
237 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 237 nTPM
  • skeletal muscle: 148 nTPM
  • heart muscle: 117 nTPM
  • prostate: 56 nTPM
  • adrenal gland: 42 nTPM
  • blood vessel: 41 nTPM

Single-cell type

  • myonuclei: 234 nCPM
  • thymic myoid cells: 177 nCPM
  • cardiomyocytes: 104 nCPM
  • müller glia: 97 nCPM
  • choroid plexus epithelial cells: 95 nCPM
  • cytotrophoblasts: 95 nCPM

Immune cell

  • T-reg: 8.8 nTPM
  • MAIT T-cell: 8 nTPM
  • NK-cell: 7.4 nTPM
  • eosinophil: 5.7 nTPM
  • myeloid DC: 5.6 nTPM
  • plasmacytoid DC: 4.4 nTPM

Brain region

  • choroid plexus: 43 nTPM
  • white matter: 31 nTPM
  • cerebral cortex: 30 nTPM
  • spinal cord: 30 nTPM
  • hypothalamus: 29 nTPM
  • basal ganglia: 28 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GPD1L.

Disease | AllUniProt

Conditions GPD1L is implicated in, by any mechanism.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.7
gnomAD pLI
0.04
gnomAD missense Z
1.08
DepMap mean gene effect
0.1
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GPD1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GPD1L as an antibody target. Whether an autoantibody or antibody against GPD1L could matter depends on whether native GPD1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GPD1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GPD1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GPD1L. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...